190 related articles for article (PubMed ID: 23973660)
1. Cost effectiveness of interferon-γ release assay for TB screening of HIV positive pregnant women in low TB incidence countries.
Kowada A
J Infect; 2014 Jan; 68(1):32-42. PubMed ID: 23973660
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
Kowada A; Takasaki J; Kobayashi N
J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of tobacco cessation support combined with tuberculosis screening among contacts who smoke.
Kowada A
Int J Tuberc Lung Dis; 2015 Jul; 19(7):857-63. PubMed ID: 26056114
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of the interferon-γ release assay for tuberculosis screening of hemodialysis patients.
Kowada A
Nephrol Dial Transplant; 2013 Mar; 28(3):682-8. PubMed ID: 23239835
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of high resolution computed tomography with interferon-gamma release assay for tuberculosis contact investigation.
Kowada A
Eur J Radiol; 2013 Aug; 82(8):1353-8. PubMed ID: 23489981
[TBL] [Abstract][Full Text] [Related]
6. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of interferon-gamma release assay for tuberculosis screening using three months of rifapentine and isoniazid among long-term expatriates from low to high incidence countries.
Kowada A
Travel Med Infect Dis; 2016; 14(5):489-498. PubMed ID: 27238907
[TBL] [Abstract][Full Text] [Related]
8. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.
Oxlade O; Schwartzman K; Menzies D
Int J Tuberc Lung Dis; 2007 Jan; 11(1):16-26. PubMed ID: 17217125
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma release assay for tuberculosis screening of solid-organ transplant recipients is cost-effective.
Kowada A
J Infect; 2019 Jan; 78(1):58-65. PubMed ID: 30009853
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of interferon-gamma release assay for school-based tuberculosis screening.
Kowada A
Mol Diagn Ther; 2012 Jun; 16(3):181-90. PubMed ID: 22594558
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of interferon-gamma release assay for entry tuberculosis screening in prisons.
Kowada A
Epidemiol Infect; 2013 Oct; 141(10):2224-34. PubMed ID: 23286364
[TBL] [Abstract][Full Text] [Related]
13. Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway.
Pullar ND; Steinum H; Tonby K; Heggelund L; Leiva RA; Ofstad R; Bruun JN; Dyrhol-Riise AM
Int J Tuberc Lung Dis; 2014 Feb; 18(2):180-7. PubMed ID: 24429310
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of interferon-gamma release assays for tuberculosis screening in nursing homes.
Kowada A
Epidemiol Infect; 2016 Nov; 144(15):3215-3225. PubMed ID: 27412626
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany.
Diel R; Nienhaus A; Loddenkemper R
Chest; 2007 May; 131(5):1424-34. PubMed ID: 17494792
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts.
Marra F; Marra CA; Sadatsafavi M; Morán-Mendoza O; Cook V; Elwood RK; Morshed M; Brunham RC; Fitzgerald JM
Int J Tuberc Lung Dis; 2008 Dec; 12(12):1414-24. PubMed ID: 19017451
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of interferon-γ release assay versus chest X-ray for tuberculosis screening of employees.
Kowada A
Am J Infect Control; 2011 Dec; 39(10):e67-72. PubMed ID: 21839543
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis.
Diel R; Wrighton-Smith P; Zellweger JP
Eur Respir J; 2007 Aug; 30(2):321-32. PubMed ID: 17504793
[TBL] [Abstract][Full Text] [Related]
20. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]